Akero Therapeutics shares traded near their all-time high as the drugmaker reported positive results in a study of its treatment for liver disease.

Akero Therapeutics shares gained 106% before the bell on Monday after the company reported results from a mid-stage trial studying its lead drug in patients with a type of liver disease.

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

Gastroenterology is a medical speciality that deals with the digestive system. The term “gastro” pertains to the stomach, and “entero” is related to the intestines; it also encompasses diseases of the ...

Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...

The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...